Bone mineral density and vitamin D receptor polymorphism in β-thalassemia major

Pakistan Journal of Pharmaceutical Sciences

Volumn 23, Issue 1, 2010, Pages 89-96

  El Edel, Rawhia H ^a   Ghonaim, Mabrouk M ^a   Abo Salem, Osama M ^a   El Nemr, Fathia M ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

thalassemia; Bone mineral density; Osteoporosis; Vitamin D receptor polymorphism

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCIUM; FERRITIN; PHOSPHORUS; PROTEIN BSM1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MALE; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SCORING SYSTEM; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; AGING; ALKALINE PHOSPHATASE; BETA-THALASSEMIA; BODY HEIGHT; BONE DENSITY; CALCIFEDIOL; CALCIUM; CHILD; CHILD, PRESCHOOL; FEMALE; FERRITINS; GENOTYPE; HUMANS; MALE; OSTEOPOROSIS; PHOSPHORUS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PUBERTY; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 75649110105     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Angelopoulos NG, Goula A, Katounda E, Rombopoulos G, Kaltzidou V, Kaltsas D, Malaktari S, Athanasiou V and Tolis G (2007). Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major. J. Bone Miner Metab., 25(1): 60-67.
2. Arabi A, Khoury N, Zahed L, Birbari A and El-Hajj, Fuleihan G (2006). Regression of skeletal manifesttations of hyperparathyroidism with oral vitamin D. J. Clin. Endocrinol. Metab., 91(7): 2480-3.
3. Arisal O, Deviren A, Fenerci EY, Hacihanefioglu S, Ulutin T, Erkmen S and Buyru N (2002). Polymorphism analysis in the COLIA1 gene of patients with thalassemia major and intermedia. Haematologia (Budap) 32(4): 475-482.
4. Bandres E, Pombo I, González-Huarriz M, Rebollo A, Lopez G and García-Foncillas J (2005). Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women. J. Clin. Endocrinol. Metab., 90(8): 4829-4835.
5. Bekheirnia MR, Abdollah Shamshirsaz A, Kamgar M, Bouzari N, Erfanzadeh G, Pourzahedgilani N, Tabatabaie SM, Abdollah Shamshirsaz A, Kimiagar M, Ezzati F and Larijani B (2994). Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents. Biol. Trace Elem. Res., 97(3): 215-224.
6. Benigno V, Bertelloni S, Baroncelli GI, Bertacca L, Di Peri S, Cuccia L, Borsellino Z and Maggio MC (2003). Effects of thalassemia major on bone mineral density in late adolescence. J. Pediatr. Endocrinol. Metab., 16(Suppl 2): 337-342.
7. Chatterton BE, Thomas CM and Schultz CG (2003). Liver density measured by DEXA correlates with serum ferritin in patients with beta-Thalassemia Major. J. Clin. Densitom., 6(3): 283-288.
8. Chen M and Chow SN (2001). Additive effect of alfacalcidol on bone mineral density of the lumbar spine in Taiwanese postmenopausal women treated with hormone replacement therapy and calcium supplementation: a randomized 2-year study. Clin. Endocrinol., (Oxf). 55(2): 253-258.
9. st edition; London; Elsevier, pp.44-46.
10. De Sanctis V, Borsari G, Brachi S, Gubellini E, Gamberini MR and Carandina G (2008). A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparathyroidism. Georgian Med. News, (156): 111-113.
11. Domrongkitchaiporn S, Sirikulchayanonta V, Angchaisuksiri P, Stitchantrakul W, Kanokkantapong C and Rajatanavin R (2003). Abnormalities in bone mineral density and bone histology in thalassemia. Bone Miner Res., 18(9): 1682-1688.
12. Dresner PR, Rachmilewitz E, Blumenfeld A, Idelson M and Goldfarb AW (2000). Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br. J. Haematol., 111(3): 902-907.
13. Dundar U, Kupesiz A, Ozdem S, Gilgil E, Tuncer T, Yesilipek A and Gultekin M (2007). Bone metabolism and mineral density in patients with beta-thalassemia major. Saudi Med. J., 28(9): 1425-1429.
14. Ferrara M, Matarese SM, Francese M, Borrelli B, Coppola A, Coppola L and Esposito L (2002). Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia. Br. J. Haematol., 117(2): 436-440.
15. Filosa A, Di Maio S, Vocca S, Saviano A, Esposito G and Pagano L (1997). Longitudinal monitoring of bone mineral density in thalassemic patients: Genetic structure and osteoporosis. Acta. Peadiatr., 86: 342-346.
16. Garnero P, Munoz F, Borel O, Sornay-Rendu E and Delmas PD (2005). Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. J. Endocrinol. Invest., 28(4): 312-321.
17. Gaudio A, Morabito N, Xourafa A, Macrì I, Meo A, Morgante S, Trifiletti A, Lasco A and Frisina N (2008). Bisphosphonates in the treatment of thalassemia-associated osteoporosis. J. Endocrinol. Invest., 31(2): 181-184.
18. La Rosa C, De Sanctis V, Mangiagli A, Mancuso M, Guardabasso V, Galati MC and Caruso-Nicoletti M (2005). Growth hormone secretion in adult patients with thalassaemia. Clin. Endocrinol., (Oxf) 62(6): 667-671.
19. Ladis VA, Gandaifis N, Papadopoulos EC, Gavras GM, Papassotiriou I, Korres DS and Kattamis CA (2004). Bone density study at the distal radius, using pQCT analysis, in Greek thalassemic patients. Pediatr. Endocrinol. Rev., 2(Suppl 2): 307-309.
20. Lo L and Singer ST (2002). Thalassemia: current approach to an old disease. Pediatr. Clinic North America, 49(6):1278-1303.
21. Lorentzon M, Lorentzon R and Nordstrom P (2000). Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy Caucasian men: a cross-sectional and longitudinal study. J. Clin. Endo. Metab., 85: 1666-1671.
22. Mahachoklertwattana P, Pootrakul P, Chuansumrit A, Choubtum L, Sriphrapradang A, Sirisriro R and Rajatanavin R (2006). Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes. J. Bone Miner Metab., 24(2): 146-152.
23. Mahacholertwattana P, Chuansmrit A, Sirisriro R, Choubtum L, Sriphrapradang A and Rajatanavin R (2003). Bone mineral density, biochemical, and hormonal profiles in sub-optimally treated children and adolescents with beta-thalassemia disease. Clin. Endocrinol., (Oxf) 58(3): 273-279.
24. Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K, Vainas E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K and Vainas I (1999). Bone mineral density of patients with thalassemia major: four-year follow-up. Calcif. Tissue Int., 64(6): 481-484.
25. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN and Eisman JA (1994). Prediction of bone density from vitamin D receptor alleles. Nature, 367: 284-287.
26. Morrison NA, George PM, Vaughan T, Tilyard MW, Frampton CM and Gilchrist NL (2006). Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Ann. Intern. Med., 145(4): 302-304.
27. Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y and Yamamoto M (2005). Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am. J. Clin. Nutr., 82(5): 1127-1133.
28. Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB and Di Fede G (2006). Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone, 38(6): 888-892.
29. Origa R, Fiumana E, Gamberini MR, Armari S, Mottes M, Sangalli A, Paglietti E, Galanello R and Borgna-Pignatti C (2005). Osteoporosis in beta-thalassemia: Clinical and genetic aspects. Ann. NY Acad. Sci., 1054: 451-456.
30. Rioja L, Girot R, Garabedian M and Cournot-Witmer G (1990). Bone disease in children with homozygous beta-thalassemia. Bone Miner, 8(1): 69-89.
31. Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P and Faglia G (2000). Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major. Endocrinol. Invest., 23(6): 356-361.
32. Skordis N, Michaelidou M, Savva SC, Ioannou Y, Rousounides A, Kleanthous M, Skordos G and Christou S (2006). The impact of genotype on endocrine complications in thalassaemia major. Eur. J. Haematol., 77(2): 150-156.
33. Soldati L, Adamo D, Bianchin C, Arcidiacono T, Terranegra A, Bianchi ML, Mora S, Cusi D and Vezzoli G (2004). Vitamin D receptor mRNA measured in leukocytes with the TaqMan fluorogenic detection system: effect of calcitriol administration. Clin. Chem., 50(8): 1315-1321.
34. Soliman AT, elZalabany MM, Ragab M, Abdel Fattah M, Hassab H, Rogol AD and Ansari BM (2000). Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty. J. Trop. Pediatr., 46(2): 79-85.
35. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A and Loukopoulos D (2001). Bone resorption is increased in young adults with thalassaemia major. Br. J. Haematol., 112(1): 36-41.
36. Voskaridou E, Terpos E, Spina G, Palermos J, Rahemtulla A, Loutradi A and Loukopoulos D (2003). Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. Br. J. Haematol., 123(4): 730-737.
37. Wu W, Zhi XM, Li DF, Lin K, Xu L and Yang YH (2007). Vitamin D receptor gene polymorphism is not associated with bone mineral density of pre-menopausal women in Guangzhou. Nan Fang Yi Ke Da Xue Xue Bao, 27(3): 364-366.
38. Zajickova K and Zokova IZ (2003). Osteoporosis: genetic analysis of multifactorial disease. Endocrine Reg., 37(1): 31-44.